Amgros 2027 1.501.a
Denmark · København Ø · how to bid here →
Your path to submission
- Deadline: 7 October at 12:00 — 3 days left.
- The submission point is stated in the notice (link on the right).
- Offer and evidence in: SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN, SWE, NOR, DAN.
- Collect your evidence — use the eligibility analysis above: it lists the requirements and, for known certificates, how to get them.
Clement What the numbers say about this buyer
- In this sector the buyer awards roughly every month (1427 awards, most recently September 2026) — the next award is due around November 2026 by that rhythm. The last award went to AstraZeneca A/S.n = 1,427
- 50% of this buyer's awards went to companies that had already won here before (2,509 awards since 2017, spread over 173 companies). That is well below the sector norm (68%) — this buyer switches suppliers more often than others.n = 2,509 awards since 2017
- The median procedure drew 3 bids (2,278 procedures with a bid count); 29% ended with a single bidder. Sector: median 4 bids.n = 2,278
- The award came in at a median 53% of the estimated value (55 awards with both estimate and value) — pricing at the estimate is usually too high here. Sector: 60%.n = 55
- 36% of awards went to companies from abroad (2,509 awards with a known winner country). Sector average: 29%.n = 2,509
From this buyer's documented awards; comparison values from the same sector and country. Not a forecast, not legal advice. As of 04/10/2026.
Foreign bidders
In Denmark · Medical equipment & pharma, 589 contracts went to foreign companies over the last 3 years (of 2,158 recorded awards) — mostly from Sweden, Germany, Finland.
Submission language: SWE.
Typical field: median 4 (from 1,418 awards).
What the buyer is looking for
The tender number (lot) includes the following medicinal products: ATC Code: B01AD02 · Generic name: Alteplase · Dispensing form: Pulv.solv.t.inj/infv · Strength: · Packing: 10 mg · Unit value: 0,1 g · Quantity in units: 969. Each lot number is considered a separate lot and is tendered independently of the other lot numbers. Thus, a supplier may choose to tender for one, several or all tender numbers, and the award is made separately for each tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender specifications, including the submission of tenders under the individual tender numbers. Under the heading "quantity in units" above, an estimated consumption of the medicinal products is indicated under the tender number, but the actual consumption may differ significantly from this. Suppliers should expect this. The reason for this is that these…
Show full description
… are medicinal products for patient treatment in public hospitals, where the patient's needs must be met. For further details, please refer to the tender specifications and the framework agreement. · The tender number (lot) includes the following medicinal products: ATC Code: B01AD02 · Generic name: Alteplase · Dispensing form: Pulv.solv.t.inj/infv · Strength: · Packing: 20 mg · Unit value: 0,1 g · Quantity in units: 99. Each lot number is considered a separate lot and is tendered independently of the other lot numbers. Thus, a supplier may choose to tender for one, several or all tender numbers, and the award is made separately for each tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender specifications, including the submission of tenders under the individual tender numbers. Under the heading "quantity in units" above, an estimated consumption of the medicinal products is indicated under the tender number, but the actual consumption may differ significantly from this. Suppliers should expect this. The reason for this is that these are medicinal products for patient treatment in public hospitals, where the patient's needs must be met. For further details, please refer to the tender specifications and the framework agreement. · The tender number (lot) includes the following medicinal products: ATC Code: B01AD02 · Generic name: Alteplase · Dispensing form: Pulv.solv.t.inj/infv · Strength: · Packing: 50 mg · Unit value: 0,1 g · Quantity in units: 498. Each lot number is considered a separate lot and is tendered independently of the other lot numbers. Thus, a supplier may choose to tender for one, several or all tender numbers, and the award is made separately for each tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender specifications, including the submission of tenders under the individual tender numbers. Under the heading "quantity in units" above, an estimated consumption of the medicinal products is indicated under the tender number, but the actual consumption may differ significantly from this. Suppliers should expect this. The reason for this is that these are medicinal products for patient treatment in public hospitals, where the patient's needs must be met. For further details, please refer to the tender specifications and the framework agreement. · The tender number (lot) includes the following medicinal products: ATC Code: B01AD11 · Generic name: Tenecteplase · Dispensing form: Solution for injection · Strength: 5000 E · Unit value: 40 mg · Quantity in units: 1633. Each lot number is considered a separate lot and is tendered independently of the other lot numbers. Thus, a supplier may choose to tender for one, several or all tender numbers, and the award is made separately for each tender number. A supplier may thus be awarded one, several or all lots. Reference is made to the tender specifications, including the submission of tenders under the individual tender numbers. Under the heading "quantity in units" above, an estimated consumption of the medicinal products is indicated under the tender number, but the actual consumption may differ significantly from this. Suppliers should expect this. Background
What you must prove — eligibility criteria
Contract
Who has won here before
| Company | Awards | Period |
|---|---|---|
| Orifarm A/S | 85 | 2024–2026 |
| 2care4 ApS · Esbjerg | 71 | 2024–2026 |
| Abacus Medicine A/S · Kopenhagen | 67 | 2024–2026 |
| Sandoz A/S | 52 | 2024–2026 |
| Pfizer ApS | 45 | 2024–2026 |
How often this buyer tenders this
Who knows the rhythm prepares instead of reacting.